Search
for
Sort by
Research 31–60 of 1000+
- Clinical Case Notes. Castleman's disease of the lacrimal gland
- Arzneimitteltherapie der Alopezien
- Antiandrogens and Androgen Inhibitors
- LOP14
- LOP14
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Oral Presentation Abstracts
- Hypertrichosis lanuginosa acquisita following cytotoxic chemotherapy
- Impact of estrogens in males and androgens in females
- Questions and Answers
- Screening: seeking a balance
- Actualités du SOPK
- Treatment options for alopecia: an update, looking to the future
- The Breast Cancer Wars: Fear, Hope and the Pursuit of a Cure in Twentieth Century America
- Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- The Black identity, hair product use, and breast cancer scale
- Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer
- Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing?
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview